Dapagliflozin May Be Cost-Effective for Chronic Kidney Disease, Review Finds
A systematic review of 14 economic evaluations across 12 countries finds dapagliflozin plus standard care may be cost-effective or dominant ...
A systematic review of 14 economic evaluations across 12 countries finds dapagliflozin plus standard care may be cost-effective or dominant ...
An analysis of 109 FDA-supported oncology trials found that Akaike and Bayesian Information Criteria showed near-zero correlation with survival extrapolation ...
A Saudi cost-utility model projects that early TAVI for asymptomatic severe aortic stenosis would save SAR 33,414 per person and ...
A review of nine European countries finds that only six of 22 licensed ATMPs were assessed by all national HTA ...
A Ministry of Health-affiliated opinion article argues Kuwait's well-resourced health system needs case-level data, financing and governance reform to deliver ...
Researchers propose a structured decision matrix to guide the selection of outcome measures in health economic evaluations of skin cancer ...
A systematic review of 28 studies finds quality, reporting and terminology problems in qualitative and mixed methods research used to ...
A participatory Malaysian study involving 84 stakeholders has produced a framework for an explicit national health benefit package, identifying seven ...
An Italian micro-costing analysis estimates first-year management costs of persistent post-surgical hypoparathyroidism at roughly €5,750 to €9,667 per patient, with ...
A Colombian study ranked five cardiovascular technologies for hospital adoption and found telemedicine leads implementation while 3D-printed heart models top ...
A model-based economic evaluation from PGIMER Chandigarh finds that adding cetuximab to radiotherapy or platinum-based chemotherapy for head and neck ...
A 2026 commentary documents India’s ADOPT programme, which uses training, stakeholder sessions and regional centres to connect health technology assessments ...
A new Italian Medicines Agency analysis shows that medicines without market competition consumed 9.6 billion euros, or 38.6 percent, of ...
A mixed-methods analysis of 1,187 Parkinson's and dementia apps finds that only about two percent claim medical device certification, while ...
A structured expert elicitation study projects substantially lower long-term organ damage risks for congenital thrombotic thrombocytopenic purpura patients receiving recombinant ...
A scoping review of 140 reports maps the statistical information-sharing methods that let meta-analysts borrow strength across sparse evidence, offering ...
A two-round expert elicitation among German and Austrian hematologists has produced a consensus list of prognostic factors and treatment-effect modifiers ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.